For research teamsHelp me find a study
Back to all studies
CompletedNCT04578756

Cariprazine for schizophrenia

This study is completed in the United States. It is testing cariprazine for schizophrenia.

Bipolarity, Schizophrenia, ...DrugFrom 5 Years to 17 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore recruiting studies on this topic

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This study is testing whether Cariprazine Flexible Dose may be useful for children experiencing bipolarity.

What would participation involve?

Participants may receive Cariprazine Flexible Dose, attend study visits with the research team. The registry lists locations in the United States.

Who is it mainly for?

This study appears to be mainly for children with bipolarity. Because it involves minors, a parent or guardian may need to be involved.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is a comparison group, how many visits or travel steps are needed, what role parents or guardians have in the process.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)

  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: February 1, 2021
Recruitment status
Completed
Enrollment listed in the registry
310
Sponsor
AbbVie
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
From 5 Years to 17 Years
Official registry ID
NCT04578756
Official title
A 52-Week, Multicenter, Open-Label, Flexible-dose Study to Evaluate the Long-term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Subjects With Schizophrenia, Bipolar I Disorder, or Autism Spectrum Disorder

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT04578756. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

Puerto Rico · 2 sites
  • Dr. Samuel Sanchez PSC /ID# 246047
    Caguas
    Site status: Not listed — confirm with the team
  • GCM Medical Group PSC /ID# 246048
    San Juan
    Site status: Not listed — confirm with the team
United States · 40 sites
  • Harmonex Neuroscience Research /ID# 234938
    Dothan, Alabama
    Site status: Not listed — confirm with the team
  • Pillar Clinical Research /ID# 236434
    Bentonville, Arkansas
    Site status: Not listed — confirm with the team
  • Advanced Research Center /ID# 241903
    Anaheim, California
    Site status: Not listed — confirm with the team
  • Duplicate_Alliance for Research - Long Beach /ID# 236261
    Long Beach, California
    Site status: Not listed — confirm with the team
  • CHOC Children's Hospital /ID# 251019
    Orange, California
    Site status: Not listed — confirm with the team
  • ATP Clinical Research- Orange /ID# 257095
    Orange, California
    Site status: Not listed — confirm with the team
  • Prospective Research Innovations Inc /ID# 236098
    Rancho Cucamonga, California
    Site status: Not listed — confirm with the team
  • University of California, San Diego Department of Psychiatry /ID# 236466
    San Diego, California
    Site status: Not listed — confirm with the team
  • Pacific Clinical Research Management Group /ID# 234377
    Upland, California
    Site status: Not listed — confirm with the team
  • D&H Doral Research Center-Doral /ID# 255459
    Doral, Florida
    Site status: Not listed — confirm with the team
  • Sarkis Clinical Trials /ID# 236893
    Gainesville, Florida
    Site status: Not listed — confirm with the team
  • Galiz Research- Palmetto Medical Plaza /ID# 236277
    Hialeah, Florida
    Site status: Not listed — confirm with the team
  • Advanced Research Institute of Miami /ID# 242505
    Homestead, Florida
    Site status: Not listed — confirm with the team
  • Duplicate_Sandhill Research LLC /ID# 251239
    Lake Mary, Florida
    Site status: Not listed — confirm with the team
  • Columbus Clinical Services, Llc /Id# 234281
    Miami, Florida
    Site status: Not listed — confirm with the team
  • G+C Research Group, LLC /ID# 261398
    Miami, Florida
    Site status: Not listed — confirm with the team
  • Florida Research Center, Inc. /ID# 236515
    Miami, Florida
    Site status: Not listed — confirm with the team
  • Links Clinical Trials /ID# 240975
    Miami, Florida
    Site status: Not listed — confirm with the team
  • South Florida Research Ph I-IV /ID# 237453
    Miami Springs, Florida
    Site status: Not listed — confirm with the team
  • K2 Medical Research - Orlando - South Orlando Avenue /ID# 257528
    Orlando, Florida
    Site status: Not listed — confirm with the team
  • APG Research, LLC /ID# 251153
    Orlando, Florida
    Site status: Not listed — confirm with the team
  • D&H Tamarac Research Center /ID# 250435
    Tamarac, Florida
    Site status: Not listed — confirm with the team
  • Atlanta Center for Medical Research /ID# 234698
    Atlanta, Georgia
    Site status: Not listed — confirm with the team
  • CenExcel iResearch LLC /ID# 237391
    Decatur, Georgia
    Site status: Not listed — confirm with the team
  • Atlanta Behavioral Research, LLC /ID# 236374
    Dunwoody, Georgia
    Site status: Not listed — confirm with the team
  • Ascension Illinois /ID# 235857
    Hoffman Estates, Illinois
    Site status: Not listed — confirm with the team
  • Med Clinical Research Partners LLC /ID# 236071
    Irvington, New Jersey
    Site status: Not listed — confirm with the team
  • Erie County Medical Center /ID# 237204
    Buffalo, New York
    Site status: Not listed — confirm with the team
  • New Dawn Psychiatric Services PLLC /ID# 236597
    Kinston, North Carolina
    Site status: Not listed — confirm with the team
  • Quest Therapeutics of Avon Lake /ID# 235956
    Avon Lake, Ohio
    Site status: Not listed — confirm with the team
  • University of Cincinnati /ID# 236913
    Cincinnati, Ohio
    Site status: Not listed — confirm with the team
  • Cincinnati Children's Hospital /ID# 251020
    Cincinnati, Ohio
    Site status: Not listed — confirm with the team
  • CincyScience /ID# 236390
    West Chester, Ohio
    Site status: Not listed — confirm with the team
  • Cutting Edge Research Group /ID# 236664
    Oklahoma City, Oklahoma
    Site status: Not listed — confirm with the team
  • BioBehavioral Research of Austin /ID# 236479
    Austin, Texas
    Site status: Not listed — confirm with the team
  • Cedar Health Research /ID# 259364
    Dallas, Texas
    Site status: Not listed — confirm with the team
  • Red Oak Psychiatry Associates /ID# 236602
    Houston, Texas
    Site status: Not listed — confirm with the team
  • AIM Trials /ID# 236368
    Plano, Texas
    Site status: Not listed — confirm with the team
  • Family Psychiatry of The Woodlands /ID# 236426
    The Woodlands, Texas
    Site status: Not listed — confirm with the team
  • Core Clinical Research /ID# 236409
    Everett, Washington
    Site status: Not listed — confirm with the team
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medication or study treatment for people with bipolarity. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving Cariprazine Flexible Dose. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.

Who might this study be for?

This study may concern people with bipolarity; age range: From 5 Years to 17 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by AbbVie, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.